Bruker Corporation
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Sci…
Medical - Devices
US, Billerica [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 61.40 | 129.02 | 79.94 | |
| Graham Fair Price | -49.44 | 8.77 | 17.34 | |
| PEG | 815.02 | -0.88 | 0.10 | |
| Price/Book | 22.81 | 9.53 | 7.76 | |
| Price/Cash Flow | 54800.93 | 33733.59 | 61.44 | |
| Prices/Earnings | 409.55 | 66.27 | 13.01 | |
| Price/Sales | 49.43 | 18.70 | 12.51 | |
| Price/FCF | 54800.93 | 33733.59 | 61.44 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -1.45 | 0.49 | 0.50 | |
| Operating Margin | -13.51 | 0.11 | 0.13 | |
| ROA | -76.64 | 0.01 | 0.05 | |
| ROE | 0.15 | 0.04 | -75.90 | |
| ROIC | 0.03 | 0.02 | -40.38 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.06 | 0.13 | -53.26 | |
| Dividends QOQ | < 0.005 | < 0.005 | -65.88 | |
| EBIT QOQ | -0.14 | -0.27 | -98.55 | |
| EPS QOQ | 1.35 | -0.75 | -44.31 | |
| FCF QOQ | 9.12 | -1.00 | -89.06 | |
| Revenue QOQ | 0.15 | -0.16 | 3.35 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 204.47 | 261.35 | 27.82 | |
| Days Sales Outstanding (DSO) | 65.49 | 79.34 | 21.14 | |
| Inventory Turnover | 0.44 | 0.34 | -21.76 | |
| Debt/Capitalization | 0.48 | 0.49 | 2.06 | |
| Quick Ratio | 0.93 | 0.84 | -10.39 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 9.47 | 9.75 | 2.98 | |
| Cash | 3.44 | 2.43 | -29.32 | |
| Capex | -0.22 | -0.15 | 31.92 | |
| Free Cash Flow | 1.20 | < 0.005 | -99.77 | |
| Revenue | 5.87 | 4.97 | -15.37 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Bad
Fundamentals
Financial Health
06 - Financial Health ·
Weak